Detalles de la búsqueda
1.
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Med Res Rev
; 43(5): 1607-1667, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036052
2.
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and µ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics.
J Med Chem
; 66(15): 10304-10341, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467430
3.
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders.
J Med Chem
; 66(3): 1809-1834, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661568
Resultados
1 -
3
de 3
1
Próxima >
>>